Salarius Pharmaceuticals Reports 2024 Financial Results and Provides Business Update
Contemplated merger with Decoy Therapeutics progressing as planned; upon closing, combined company expected to accelerate clinical development of novel peptide conjugate therapeutics for treating respiratory viruses and cancer Updates expected…
Alcon Agrees to Acquire LENSAR, Inc.
Acquisition of ALLY Robotic Cataract Laser Systems strengthens Alcon’s cataract equipment and technology portfolioNext generation technology will be expanded globally, improving the efficiency of cataract surgery GENEVA and ORLANDO, Fla.,…
Viamedia Acquires LocalFactor to Transform Digital Ad Operations, Unlock Greater Precision, Reach, Efficiency and Results Across Linear TV, Streaming and Digital
LocalFactor Founder & CEO Evan Rutchik Named Viamedia President & Chief Strategy Officer Acquisition Combines Viamedia’s Extensive Infrastructure with LocalFactor’s Data-Driven Targeting and Programmatic Expertise to Deliver More Scalable, Privacy-Compliant…
Verisk Nominates Christopher Perry and Sabra Purtill to the Company’s Board of Directors
Jersey City, N.J., March 21, 2025 (GLOBE NEWSWIRE) -- Verisk, a leading global data analytics and technology provider, today announced that its Board of Directors has nominated to stand for…
Brookfield Property Partners Completes 2024 Annual Filings
BROOKFIELD NEWS, March 21, 2025 (GLOBE NEWSWIRE) -- Brookfield Property Partners announced today that it has filed its 2024 annual report on Form 20-F, including its audited financial statements for…
Maxim Power Corp. Reports 2024 Financial and Operating Results with Revenue of $101 million and Record Annual Generation from M2
CALGARY, Alberta, March 21, 2025 (GLOBE NEWSWIRE) -- Maxim Power Corp. ("MAXIM" or the "Corporation") (TSX: MXG) announced today the release of financial and operating results for the fourth quarter…
Atea Pharmaceuticals Issues Statement Regarding Director Nominations
BOSTON, March 21, 2025 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (Atea or Company) a clinical-stage biopharmaceutical company engaged in the discovery and development of oral antiviral therapeutics for…
LEADING EDGE MATERIALS REPORTS QUARTERLY RESULTS TO JANUARY 31, 2025
LEADING EDGE MATERIALS REPORTS QUARTERLY RESULTS TO JANUARY 31, 2025 Vancouver, March 21, 2025 – Leading Edge Materials Corp. (“Leading Edge Materials” or the “Company”) (TSXV: LEM) (Nasdaq First North:…
Eros Resources Announces Non-Brokered Private Placement Financing
Vancouver, BC, March 21, 2025 (GLOBE NEWSWIRE) -- Eros Resources Corp. (TSXV:ROCK) (OTCQB:EROSF) (“Eros” or the “Company”) is pleased to announce a non-brokered private placement financing of up to 36,000,000…
Glacier Reports Year End 2024 Results
VANCOUVER, British Columbia, March 21, 2025 (GLOBE NEWSWIRE) -- Glacier Media Inc. (TSX: GVC) (“Glacier” or the “Company”) reported revenue and earnings for the year ended December 31, 2024. Summary…